Baseline Characteristics in Subjects With NDR Compared to Those With DR at Diagnosis of T2DM
| . | All Subjects . | NDR . | DR . | P Value . |
|---|---|---|---|---|
| Group A | ||||
| Number | 544 | 454 | 90 | |
| Age at presentation (years) | 54 (10) | 54 (10) | 56 (11) | .28 |
| Male sex (%) | 393 (72) | 324 (71) | 69 (77) | .31 |
| Weight (kg) | 88 (17) | 88 (17) | 85 (19) | .02 |
| BMI (kg/m2) | 30.2 (5.0) | 30.4 (5.3) | 29.6 (5.8) | .06 |
| Systolic BP (mmHg) | 137 (19) | 137 (20) | 139 (18) | .25 |
| Diastolic BP (mmHg) | 83 (11) | 83 (11) | 83 (11) | .71 |
| Total cholesterol (mmol/liter) | 5.4 (1.2) | 5.5 (1.2) | 5.2 (1.2) | .08 |
| HbA1c (%) [mmol/mol] | 7.7 (2.0) [61] (22) | 7.7 (2.0) [61] (22) | 8.0 (1.8) [64] (20) | .06 |
| Group B | ||||
| Number | 201 | 171 | 30 | |
| Age at presentation (years) | 55 (10) | 55 (10) | 55 (11) | .79 |
| Male sex | 145 (72) | 125 (73) | 20 (67) | .47 |
| Weight (kg) | 90 (17) | 91 (16.7) | 86 (16.5) | .16 |
| BMI (kg/m2) | 31.2 (5.5) | 31.3 (5.6) | 30.6 (4.8) | .54 |
| Systolic BP (mmHg) | 135 (19) | 135 (18) | 134 (19) | .68 |
| Diastolic BP (mmHg) | 81 (10) | 81 (10) | 81 (10) | .95 |
| Total cholesterol (mmol/liter) | 5.4 (1.1) | 5.4 (1.2) | 5.4 (1.0) | .77 |
| HbA1c (%) [mmol/mol] | 7.6 (1.9) [61] (21) | 7.6 (2.0) [61] (22) | 7.7 (1.5) [61] (17) | .80 |
| . | All Subjects . | NDR . | DR . | P Value . |
|---|---|---|---|---|
| Group A | ||||
| Number | 544 | 454 | 90 | |
| Age at presentation (years) | 54 (10) | 54 (10) | 56 (11) | .28 |
| Male sex (%) | 393 (72) | 324 (71) | 69 (77) | .31 |
| Weight (kg) | 88 (17) | 88 (17) | 85 (19) | .02 |
| BMI (kg/m2) | 30.2 (5.0) | 30.4 (5.3) | 29.6 (5.8) | .06 |
| Systolic BP (mmHg) | 137 (19) | 137 (20) | 139 (18) | .25 |
| Diastolic BP (mmHg) | 83 (11) | 83 (11) | 83 (11) | .71 |
| Total cholesterol (mmol/liter) | 5.4 (1.2) | 5.5 (1.2) | 5.2 (1.2) | .08 |
| HbA1c (%) [mmol/mol] | 7.7 (2.0) [61] (22) | 7.7 (2.0) [61] (22) | 8.0 (1.8) [64] (20) | .06 |
| Group B | ||||
| Number | 201 | 171 | 30 | |
| Age at presentation (years) | 55 (10) | 55 (10) | 55 (11) | .79 |
| Male sex | 145 (72) | 125 (73) | 20 (67) | .47 |
| Weight (kg) | 90 (17) | 91 (16.7) | 86 (16.5) | .16 |
| BMI (kg/m2) | 31.2 (5.5) | 31.3 (5.6) | 30.6 (4.8) | .54 |
| Systolic BP (mmHg) | 135 (19) | 135 (18) | 134 (19) | .68 |
| Diastolic BP (mmHg) | 81 (10) | 81 (10) | 81 (10) | .95 |
| Total cholesterol (mmol/liter) | 5.4 (1.1) | 5.4 (1.2) | 5.4 (1.0) | .77 |
| HbA1c (%) [mmol/mol] | 7.6 (1.9) [61] (21) | 7.6 (2.0) [61] (22) | 7.7 (1.5) [61] (17) | .80 |
Data expressed as mean (±sd); sex: number (%).Group A, 544 subjects underwent MTT; group B, 201 subjects underwent FSIVGTT.
Baseline Characteristics in Subjects With NDR Compared to Those With DR at Diagnosis of T2DM
| . | All Subjects . | NDR . | DR . | P Value . |
|---|---|---|---|---|
| Group A | ||||
| Number | 544 | 454 | 90 | |
| Age at presentation (years) | 54 (10) | 54 (10) | 56 (11) | .28 |
| Male sex (%) | 393 (72) | 324 (71) | 69 (77) | .31 |
| Weight (kg) | 88 (17) | 88 (17) | 85 (19) | .02 |
| BMI (kg/m2) | 30.2 (5.0) | 30.4 (5.3) | 29.6 (5.8) | .06 |
| Systolic BP (mmHg) | 137 (19) | 137 (20) | 139 (18) | .25 |
| Diastolic BP (mmHg) | 83 (11) | 83 (11) | 83 (11) | .71 |
| Total cholesterol (mmol/liter) | 5.4 (1.2) | 5.5 (1.2) | 5.2 (1.2) | .08 |
| HbA1c (%) [mmol/mol] | 7.7 (2.0) [61] (22) | 7.7 (2.0) [61] (22) | 8.0 (1.8) [64] (20) | .06 |
| Group B | ||||
| Number | 201 | 171 | 30 | |
| Age at presentation (years) | 55 (10) | 55 (10) | 55 (11) | .79 |
| Male sex | 145 (72) | 125 (73) | 20 (67) | .47 |
| Weight (kg) | 90 (17) | 91 (16.7) | 86 (16.5) | .16 |
| BMI (kg/m2) | 31.2 (5.5) | 31.3 (5.6) | 30.6 (4.8) | .54 |
| Systolic BP (mmHg) | 135 (19) | 135 (18) | 134 (19) | .68 |
| Diastolic BP (mmHg) | 81 (10) | 81 (10) | 81 (10) | .95 |
| Total cholesterol (mmol/liter) | 5.4 (1.1) | 5.4 (1.2) | 5.4 (1.0) | .77 |
| HbA1c (%) [mmol/mol] | 7.6 (1.9) [61] (21) | 7.6 (2.0) [61] (22) | 7.7 (1.5) [61] (17) | .80 |
| . | All Subjects . | NDR . | DR . | P Value . |
|---|---|---|---|---|
| Group A | ||||
| Number | 544 | 454 | 90 | |
| Age at presentation (years) | 54 (10) | 54 (10) | 56 (11) | .28 |
| Male sex (%) | 393 (72) | 324 (71) | 69 (77) | .31 |
| Weight (kg) | 88 (17) | 88 (17) | 85 (19) | .02 |
| BMI (kg/m2) | 30.2 (5.0) | 30.4 (5.3) | 29.6 (5.8) | .06 |
| Systolic BP (mmHg) | 137 (19) | 137 (20) | 139 (18) | .25 |
| Diastolic BP (mmHg) | 83 (11) | 83 (11) | 83 (11) | .71 |
| Total cholesterol (mmol/liter) | 5.4 (1.2) | 5.5 (1.2) | 5.2 (1.2) | .08 |
| HbA1c (%) [mmol/mol] | 7.7 (2.0) [61] (22) | 7.7 (2.0) [61] (22) | 8.0 (1.8) [64] (20) | .06 |
| Group B | ||||
| Number | 201 | 171 | 30 | |
| Age at presentation (years) | 55 (10) | 55 (10) | 55 (11) | .79 |
| Male sex | 145 (72) | 125 (73) | 20 (67) | .47 |
| Weight (kg) | 90 (17) | 91 (16.7) | 86 (16.5) | .16 |
| BMI (kg/m2) | 31.2 (5.5) | 31.3 (5.6) | 30.6 (4.8) | .54 |
| Systolic BP (mmHg) | 135 (19) | 135 (18) | 134 (19) | .68 |
| Diastolic BP (mmHg) | 81 (10) | 81 (10) | 81 (10) | .95 |
| Total cholesterol (mmol/liter) | 5.4 (1.1) | 5.4 (1.2) | 5.4 (1.0) | .77 |
| HbA1c (%) [mmol/mol] | 7.6 (1.9) [61] (21) | 7.6 (2.0) [61] (22) | 7.7 (1.5) [61] (17) | .80 |
Data expressed as mean (±sd); sex: number (%).Group A, 544 subjects underwent MTT; group B, 201 subjects underwent FSIVGTT.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
